1 / 10

OTIS Autoimmune Diseases in Pregnancy Study

OTIS Autoimmune Diseases in Pregnancy Study. OTIS Annual Research Meeting June 2010. Background. Project began in 2000 with one sponsor, Sanofi -Aventis, to prospectively follow women exposed to leflunomide for the treatment of rheumatoid arthritis

killian
Download Presentation

OTIS Autoimmune Diseases in Pregnancy Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OTIS Autoimmune Diseases in Pregnancy Study OTIS Annual Research Meeting June 2010

  2. Background Project began in 2000 with one sponsor, Sanofi-Aventis, to prospectively follow women exposed to leflunomide for the treatment of rheumatoid arthritis The Project is currently funded by eight pharmaceutical companies Prospective, observational cohort study Coordinating center is at the University of California, San Diego

  3. Purpose The purpose of the research study is to evaluate the risks to the developing fetus from autoimmune diseases and the safety of medications used to treat these diseases during pregnancy.

  4. Study Participation • Self-enrollment • 3-4 phone interviews (intake, 20wk, 32wk, outcome) • Medical records pertaining to the pregnancy and outcome of the pregnancy • Free non-invasive pediatric exam

  5. Total Enrollment to Date

  6. AI Cohort Study Totals

  7. Recruitment

  8. Marketing Plans 2010 • Scientific Meetings: • 16 trade shows • Quarterly Mailings and Email Updates • Journal Advertisements • Internet Advertisements

  9. Who Should be Referred?

  10. How to Refer? • Toll-free number at 877-311-8972 to refer patient OR provide the patient our toll-free number • Contact via email at d4johnson@ucsd.edu • Fax a referral sheet to OTIS which is found on our website at www.otispregnancy.org

More Related